These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 34915086)

  • 1. Use of Sanger protocols to identify variants of concern, key mutations and track evolution of SARS-CoV-2.
    Cabral GB; Ahagon CM; de Souza Guimarães PM; Silva Lopez-Lopes GI; Hussein IM; Cilli A; de Jesus Alves I; Coelho Bombonatte AG; do Carmo Sampaio Tavares Timenetsky M; da Silva Santos JH; de Oliveira Santos KC; Dos Santos FCP; de Macedo Brígido LF
    J Virol Methods; 2022 Feb; 300():114422. PubMed ID: 34915086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emergency SARS-CoV-2 Variants of Concern: Novel Multiplex Real-Time RT-PCR Assay for Rapid Detection and Surveillance.
    Chung HY; Jian MJ; Chang CK; Lin JC; Yeh KM; Chen CW; Hsieh SS; Hung KS; Tang SH; Perng CL; Chang FY; Wang CH; Shang HS
    Microbiol Spectr; 2022 Feb; 10(1):e0251321. PubMed ID: 35196812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Routine Sanger Sequencing Target Specific Mutation Assay for SARS-CoV-2 Variants of Concern and Interest.
    Lee SH
    Viruses; 2021 Nov; 13(12):. PubMed ID: 34960655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Developing an Amplification Refractory Mutation System-Quantitative Reverse Transcription-PCR Assay for Rapid and Sensitive Screening of SARS-CoV-2 Variants of Concern.
    Xiong D; Zhang X; Shi M; Wang N; He P; Dong Z; Zhong J; Luo J; Wang Y; Yu J; Wei H
    Microbiol Spectr; 2022 Feb; 10(1):e0143821. PubMed ID: 34985323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid screening for SARS-CoV-2 variants of concern in clinical and environmental samples using nested RT-PCR assays targeting key mutations of the spike protein.
    La Rosa G; Mancini P; Bonanno Ferraro G; Veneri C; Iaconelli M; Lucentini L; Bonadonna L; Brusaferro S; Brandtner D; Fasanella A; Pace L; Parisi A; Galante D; Suffredini E
    Water Res; 2021 Jun; 197():117104. PubMed ID: 33857895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spike Mutation Profiles Associated With SARS-CoV-2 Breakthrough Infections in Delta Emerging and Predominant Time Periods in British Columbia, Canada.
    Fibke CD; Joffres Y; Tyson JR; Colijn C; Janjua NZ; Fjell C; Prystajecky N; Jassem A; Sbihi H
    Front Public Health; 2022; 10():915363. PubMed ID: 35859775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolutionary and Phenotypic Characterization of Two Spike Mutations in European Lineage 20E of SARS-CoV-2.
    Ruiz-Rodriguez P; Francés-Gómez C; Chiner-Oms Á; López MG; Jiménez-Serrano S; Cancino-Muñoz I; Ruiz-Hueso P; Torres-Puente M; Bracho MA; D'Auria G; Martinez-Priego L; Guerreiro M; Montero-Alonso M; Gómez MD; Piñana JL; ; González-Candelas F; Comas I; Marina A; Geller R; Coscolla M
    mBio; 2021 Dec; 12(6):e0231521. PubMed ID: 34781748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular and Serological Characterization of the SARS-CoV-2 Delta Variant in Bangladesh in 2021.
    Ghosh AK; Kaiser M; Molla MMA; Nafisa T; Yeasmin M; Ratul RH; Sharif MM; Akram A; Hosen N; Mamunur R; Amin MR; Islam A; Hoque ME; Landt O; Lytton SD
    Viruses; 2021 Nov; 13(11):. PubMed ID: 34835116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Temporal-Geographical Dispersion of SARS-CoV-2 Spike Glycoprotein Variant Lineages and Their Functional Prediction Using
    Boon SS; Xia C; Wang MH; Yip KL; Luk HY; Li S; Ng RWY; Lai CKC; Chan PKS; Chen Z
    mBio; 2021 Oct; 12(5):e0268721. PubMed ID: 34700382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging mutation patterns in SARS-CoV-2 variants.
    Ostrov DA; Knox GW
    Biochem Biophys Res Commun; 2022 Jan; 586():87-92. PubMed ID: 34837837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequencing Using a Two-Step Strategy Reveals High Genetic Diversity in the S Gene of SARS-CoV-2 after a High-Transmission Period in Tunis, Tunisia.
    Fares W; Ghedira K; Gdoura M; Chouikha A; Haddad-Boubaker S; Khedhiri M; Ayouni K; Lamari A; Touzi H; Hammemi W; Medeb Z; Sadraoui A; Hogga N; Ben Alaya N; Triki H
    Microbiol Spectr; 2021 Dec; 9(3):e0063921. PubMed ID: 34756072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SARS-CoV-2 Variants of Concern: Presumptive Identification via Sanger Sequencing Analysis of the Receptor Binding Domain (RBD) Region of the
    Rodrigues GM; Volpato FCZ; Wink PL; Paiva RM; Barth AL; de-Paris F
    Diagnostics (Basel); 2023 Mar; 13(7):. PubMed ID: 37046474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CRISPR-Cas12a-Based Detection for the Major SARS-CoV-2 Variants of Concern.
    Liang Y; Lin H; Zou L; Zhao J; Li B; Wang H; Lu J; Sun J; Yang X; Deng X; Tang S
    Microbiol Spectr; 2021 Dec; 9(3):e0101721. PubMed ID: 34787487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SARS-COV-2 RBD (Receptor binding domain) mutations and variants (A sectional-analytical study).
    Hajizadeh F; Khanizadeh S; Khodadadi H; Mokhayeri Y; Ajorloo M; Malekshahi A; Heydari E
    Microb Pathog; 2022 Jul; 168():105595. PubMed ID: 35597364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mass Screening of SARS-CoV-2 Variants using Sanger Sequencing Strategy in Hiroshima, Japan.
    Ko K; Takahashi K; Nagashima S; E B; Ouoba S; Hussain MRA; Akita T; Sugiyama A; Sakaguchi T; Tahara H; Ohge H; Ohdan H; Kubo T; Ishikawa N; Takafuta T; Fujii Y; Mimori M; Okada F; Kishita E; Ariyoshi K; Kuwabara M; Tanaka J
    Sci Rep; 2022 Feb; 12(1):2419. PubMed ID: 35165301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Receptor-Binding-Motif-Targeted Sanger Sequencing: a Quick and Cost-Effective Strategy for Molecular Surveillance of SARS-CoV-2 Variants.
    Chaki SP; Kahl-McDonagh MM; Neuman BW; Zuelke KA
    Microbiol Spectr; 2022 Jun; 10(3):e0066522. PubMed ID: 35638906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transformations, Lineage Comparisons, and Analysis of Down-to-Up Protomer States of Variants of the SARS-CoV-2 Prefusion Spike Protein, Including the UK Variant B.1.1.7.
    Peters MH; Bastidas O; Kokron DS; Henze CE
    Microbiol Spectr; 2021 Sep; 9(1):e0003021. PubMed ID: 34346753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular biology of SARS-CoV-2 and techniques of diagnosis and surveillance.
    Ishige T
    Adv Clin Chem; 2024; 118():35-85. PubMed ID: 38280807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual-Domain Reporter Approach for Multiplex Identification of Major SARS-CoV-2 Variants of Concern in a Microarray-Based Assay.
    Damin F; Galbiati S; Clementi N; Ferrarese R; Mancini N; Sola L; Chiari M
    Biosensors (Basel); 2023 Feb; 13(2):. PubMed ID: 36832035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genomic Surveillance of SARS-CoV-2 Lineages Indicates Early Circulation of P.1 (Gamma) Variant of Concern in Southern Brazil.
    Wink PL; Ramalho R; Monteiro FL; Volpato FCZ; Willig JB; Lovison OVA; Zavascki AP; Barth AL; Martins AF
    Microbiol Spectr; 2022 Feb; 10(1):e0151121. PubMed ID: 35171035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.